RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | -83.3% | 336 | -73.9% | 0.00% | – |
| Q4 2021 | $12,000 | -47.8% | 1,286 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -28.1% | 1,286 | -3.3% | 0.00% | – |
| Q2 2021 | $32,000 | -5.9% | 1,330 | +3.4% | 0.00% | – |
| Q1 2021 | $34,000 | +240.0% | 1,286 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | +900.0% | 1,286 | +533.5% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 203 | -22.5% | 0.00% | – |
| Q1 2020 | $1,000 | – | 262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $13,118,000 | 65.48% |
| Flagship Pioneering Inc. | 38,296,526 | $191,866,000 | 5.30% |
| Abbot Financial Management, Inc. | 563,500 | $2,823,000 | 1.83% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,944,000 | 1.83% |
| Artal Group S.A. | 3,778,913 | $18,932,000 | 0.46% |
| Virtus ETF Advisers LLC | 50,863 | $255,000 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 402,555 | $2,017,000 | 0.02% |
| PDT Partners, LLC | 49,500 | $248,000 | 0.02% |
| Baillie Gifford | 4,273,861 | $21,413,000 | 0.02% |
| Trexquant Investment LP | 36,363 | $182,000 | 0.01% |